Application Notes:
This product contains ceramides with both hydroxy and non-hydroxy fatty acids. Ceramide is a fatty acid amide of
sphingosine. Ceramide functions as a precursor in the synthesis of sphingomyelin, glycosphingolipids, and of free
sphingosine and fatty acids. The sphingosine can be phosphorylated to form sphingosine-1-phosphate. Two of ceramide’s
metabolites, sphingosine-1-phosphate and glucosylceramide, produce cell proliferation and other cellular functions.1
Ceramide exerts numerous biological effects, including induction of cell maturation, cell cycle arrest, terminal cell
differentiation, cell senescence, and cell death.2 Because of these effects ceramide has been investigated for its use in cancer
treatment and many potential approaches to cancer therapy have been presented.3 Other effects include producing reactive
oxygen in mitochondria (followed by apoptosis) and stimulating phosphorylation of certain proteins (especially mitogen
activated protein). It also stimulates some protein phosphatases (especially protein phosphatase 2A) making it an important
controller of protein activity. 2-hydroxy fatty acid ceramides are especially abundant in nervous and epidermal cells. These
ceramides are important for the permeability barrier function of epidermis and the lipid organization in membranes. The 2-
hydroxylation is catalyzed by fatty acid 2-hydroxylase (FA2H or fatty acid alpha-hydroxylase).
References:
1. J. M. L. Hauser et al., J. Biol. Chem. 269, 6803, 1994
2. N. S. Radin, “Killing tumours by ceramide-induced apoptosis: a critique of available drugs” Biochemical Journal, Vol. 371 pp. 243-256, 2003
3. N. S. Radin, “Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria” Bioorganic and Medicinal Chemistry, Vol.
11(10) pp. 2123-2142, 2003